Rare Disease Case Study
Over 90% of rare diseases have no treatment…
Understanding the rare disease framework is key to be able to offer study participants adapted solutions and as such, positively contribute to important and necessary clinical research conducted on rare diseases.
Kayentis offers an extensive experience in rare disease clinical trials, in indications such as:
Learn more:
Arthritis is a general term categorized by acute or chronic inflammation of the joints. Arthritis
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data
What rare disease patients and families want is a simpler life. Discover here what makes
A patient association in rare diseases is first and foremost families who all have one
Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience.
Improve your eCOA data collection and clinical trial efficiency thanks to Kayentis and ClinOne combined
Last update : 30 March 2023
